Indian biotechnology company and vaccine manufacturer
Bharat Biotech ▸ Facts ▸ Comments ▸ News ▸ Videos
TN Health Min takes Bharat Biotech's Covaxin shot in Chennai
Credit: ANI Duration: 01:28Published
Healthcare workers should be given choice in vaccines: Karnataka resident doctors
Credit: ANI Duration: 01:30Published
Covid vaccine: How many Indians got jab on Day 1? Govt reveals
Credit: HT Digital Content Duration: 06:46Published
First feeling, side-effects, doubts: Vaccinated doctors share experience
Credit: HT Digital Content Duration: 08:15Published
Covid: Dr VK Paul, AIIMS director urge people to trust researchers on vaccine
Credit: HT Digital Content Duration: 03:41Published
Vaccine will work as 'sanjeevani' in fight against COVID-19: Harsh Vardhan
Credit: ANI Duration: 01:42Published
'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive
Credit: HT Digital Content Duration: 03:02Published
‘Covaxin will also provide immunity against Covid mutants’: ICMR scientist
Credit: HT Digital Content Duration: 04:36Published
Free Covid vaccine for Delhi residents? CM Kejriwal comments ahead of launch
Credit: HT Digital Content Duration: 02:39Published
Watch: 1st batch of Covaxin reaches Delhi; Mumbai receives Covishield
Credit: HT Digital Content Duration: 02:02Published
First batch of Bharat Biotech's 'Covaxin' arrives at Delhi airport
Credit: ANI Duration: 01:18Published
Covid vaccine: States that received 1st dispatch ahead of Jan 16 roll-out
Credit: HT Digital Content Duration: 03:31Published
BBIL to provide 16.50 lakh doses of COVAXIN for free to GoI: Health Ministry
Credit: ANI Duration: 01:23Published
These temperature-controlled trucks set to transport COVID vaccine from Serum Institute of India
Credit: ANI Duration: 03:09Published
Covid vaccine: Congress minister's appeal to Modi govt after Jan 16 launch move
Credit: HT Digital Content Duration: 03:58Published
You Might Like
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet studyIndia's first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the..
Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccineAn expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech,..
Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of CovaxinBharat Biotech has secured a fresh Letter of Comfort from the Centre for another 45 lakh doses of its COVID-19 vaccine, Covaxin, sources said. Out of the 45 lakh doses, the city-based vaccine..
COVID-19: Who shouldn't take Covaxin? Bharat Biotech releases factsheet as concerns growBharat Biotech issued the factsheet just two days after the launch of vaccination drive in the country.
COVID-19: Bharat Biotech to pay compensation for any side effect of Covaxin, details hereBharat Biotech, has received a government purchase order for the supply of 55 lakh doses of Covaxin.
Compensation if Covaxin causes serious adverse effectBeneficiaries who receive Covaxin, a Bharat Biotech product, will be paid a compensation if they suffer a serious adverse event that is proven to be causally related to the vaccine. Beneficiaries of..
India plans 20 million doses of vaccine supply to neighboursIndia plans to offer 20 million doses of coronavirus vaccine to its neighbours as it draws up a policy to supply vials to countries across the globe, people with knowledge of the matter said. An Indian..
Experts question govt vaccine purchase price, say it’s higherAs the Covid-19 vaccine completes its journey from laboratory to hospital, its pricing is being questioned. Public health activists and industry experts to whom TOI spoke said the government’s..
Vaccine drive accelerates, doses reach far corners of IndiaWhile SII moved about 56 lakh doses of Covishield to 13 cities, Hyderabad-based Bharat Biotech said it had successfully transported the indigenous Covaxin, developed in collaboration with the ICMR and..
Bharat Biotech commences dispatch of Covaxin, ships to 11 citiesVaccine maker Bharat Biotech commenced dispatches of indigenous Covid-19 vaccine Covaxin on Wednesday morning with the first lot of the vaccine doses being flown out of Hyderabad by national carrier..
After Covishield, first batch of Bharat Biotech's Covaxin arrives in DelhiBoth Covishield and Covaxin, the two COVID-19 vaccines, have received Emergency Use Authorisation from the government.
Covid vaccine recipients may not be able to pick & chooseEven as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they..
Bharat Biotech inks pact to supply Covaxin to BrazilVaccine maker Bharat Biotech on Tuesday said it has inked an agreement with Brazil’s Precisa Medicamentos for distribution of India’s first indigenous Covid-19 vaccine Covaxin in the Brazilian..
54.72 lakh Covid-19 vaccine doses received till Tuesday afternoon: CentreThe Centre said 54.72 lakh Covid-19 vaccine doses have been received at designated national and state-level stores till Tuesday afternoon, and all the shots -- 1.1 crore from the Serum Institute of..
Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for Covid-19 in Feb-MarchBuoyed by the Emergency Use Authorisation approval from the Drug Controller General of India (DCGI)for its Covid-19 vaccine Covaxin, Bharat Biotech has said Phase-1 clinical trials of its new..
Covid-19: Bharat Biotech enrolls 25,800 volunteers for Covaxin phase-3 clinical trials
All-India vaccine rollout set for next week: GovtThe government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
Bharat Biotech, Serum Institute pledge for smooth rollout of Covid-19 vaccinesVaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of Covid-19 vaccines in the country and the world.
Why Covaxin may have an edge against new virus variantsThe chairman and managing director of Bharat Biotech, Dr Kishna Ella, said its Covid-19 vaccine, Covaxin, would be effective on mutant strains of the coronavirus, and therefore is justified to receive..
Carried out 200% honest trials, don't deserve this backlash: Bharat Biotech hits back at criticsSome opposition leaders and scientific researchers criticised Covaxin for being given emergency use authorisation without completion of phase 3 trials
Vaccine war: Bharat Biotech chief lashes out at SerumBharat Biotech founder and chairman Dr Krishna Ella on Monday lashed out at detractors who criticised the speed at which emergency use authorisation (EUA) was given to Covaxin, the company’s Covid-19..
Covaxin not water-like or backup vaccine, trials 200% honest: Bharat Biotech CEO
Bharat Biotech aims to make 700 million doses of Covid-19 vaccine in 2021The vaccine candidate, Covaxin, received emergency use approval from India's drugs regulator on Sunday. "We have four facilities coming up and we are planning (to make) around 200 million doses in..
Centre taking up Covid-19 vaccination in a big way: Harsh VardhanUnion health and family welfare minister Dr Harsh Vardhan on Monday said the Centre has initiated a series of actions to prevent the spread of coronavirus and that it is now taking up the vaccination..
DCGI allows Bharat Biotech to conduct vaccine trials on children above 12Covaxin has already been used on children above 12 in phase I and II trials and has been found safe.
Brazil private clinics seek deal for Indian Covid vaccineA Brazilian association of private health clinics said Sunday it was negotiating with Indian pharmaceutical firm Bharat Biotech to buy five million doses of its Covid-19 vaccine, which India has just..
Coronavirus vaccine price: SII CEO reveals how much it will costCOVID-19 vaccines of Serum Institue of India and Bharat Biotech were granted permission for restricted use in an emergency situation on Sunday.
Submitted all data as per guidelines, says Bharat Biotech
Bharat Biotech vaccine more likely to work against newer strains like UK variant: Vardhan
ICMR says clinical trial shows COVAXIN is 'safe'Notably, COVAXIN is an indigenously developed coronavirus vaccine manufactured by Bharat Biotech in collaboration with the ICMR.
Govt must explain why international protocols were disregarded to approve Bharat Biotech’s Covaxin, Congress leaders say
Opposition parties not proud of anything Indian, alleges Nadda as Congress and BJP spar over Covid vaccine issueThe BJP on Sunday hit out at the Congress after some of its leaders questioned the approval process for Bharat Biotech's Covid-19 vaccine, with party president J P Nadda alleging that whenever India..
WHO welcomes India's emergency use authorisation approval to COVID-19 vaccinesThe COVID-19 vaccines of the Serum Institute of India and Bharat Biotech have been granted permission for restricted use in an emergency situation.
Great milestone in India's scientific capability: Bharat Biotech after DCGI approval to CovaxinThe Hyderabad-based vaccine maker expressed its delight after DCGI granted permission for emergency use of its Covid-19 vaccine.
'Watershed moment in India's battle against COVID': Politicos react over emergency use approvalDCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
India approves Oxford's, Bharat Biotech's Covid-19 vaccines for restricted emergency use
Congress leaders raise concern over grant of permission for restricted use of Covid-19 vaccineSenior Congress leader Anand Sharma on Sunday raised concerns over India's drugs regulator granting permission for restricted use of Bharat Biotech's Covid-19 vaccine and asked the government to..
BREAKING: DCGI grants approval to Serum Institute, Bharat Biotech's COVID-19 vaccinesThe approval comes after the clearances from the Subject Expert Committee (SEC).
COVID-19: Bharat Biotech recruits 23,000 volunteers for Phase III trials of CovaxinThe phase III human clinical trials of Covaxin began mid-November, targeted to be done in 26,000 volunteers across India.
Also reported by •IndiaTimes
Bharat Biotech’s Covaxin too gets nod for emergency useIndia's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
After Covishield, India's Covaxin gets expert panel nod for emergency useAn expert panel of India's drug authority on Saturday recommended restricted emergency use of Bharat Biotech's Covaxin. The development comes a day after the panel recommended emergency use..
CDSCO panel recommends granting approval for Bharat Biotech's Covaxin
Covaxin vaccine: DCGI panel to meet Bharat Biotech officials shortly
No approval for Covaxin, expert panel seeks more data from Bharat BiotechThe Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for..
UK approves Oxford vaccine, raising hopes for India rolloutIndia's subject expert committee that met on Wednesday sought more data relating to the vaccine's immunogenicity, which will mean the emergency-use approval may take a few more days. The committee is..
Covaxin can offer protection against mutated coronavirus: Bharat BiotechVaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain.
Bharat Biotech bosses discuss Covaxin status with Vice President M Venkaiah NaiduThey discussed the status of the indigenous vaccine, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology, and the plans..
Also reported by •DNA
Indian vaccine Covaxin has drawn global attention: ICMRThe Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, "India's indigenous vaccine against..
Antibodies generated by Covaxin may persist for 6-12 months: Bharat Biotech
Covaxin Phase III trials hit halfway mark with 13K volunteersCovaxin, India's first indigenous Covid-19 vaccine being developed by Hyderabad-based Bharat Biotech, has been successful in roping in 13,000 volunteers for its Phase III trials, which is half the..